TITLE

Nutritional management and growth in children with chronic kidney disease

AUTHOR(S)
Rees, Lesley; Jones, Helen
PUB. DATE
April 2013
SOURCE
Pediatric Nephrology;Apr2013, Vol. 28 Issue 4, p527
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Despite continuing improvements in our understanding of the causes of poor growth in chronic kidney disease, many unanswered questions remain: why do some patients maintain a good appetite whereas others have profound anorexia at a similar level of renal function? Why do some, but not all, patients respond to increased nutritional intake? Is feed delivery by gastrostomy superior to oral and nasogastric routes? Do children who are no longer in the 'infancy' stage of growth benefit from enteral feeding? Do patients with protein energy wasting benefit from increased nutritional input? How do we prevent obesity, which is becoming so prevalent in the developed world? This review will address these issues.
ACCESSION #
85873408

 

Related Articles

  • Chapter 3: Assessment of lipid status in children with CKD.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p280 

    The article presents information on a study related to children with newly identified chronic kidney disease (CDK) and recommends evaluation with a lipid profile. Topics include prediction of lipid levels in children for future cardiovascular events, relationship between dyslipidemias and...

  • Chapter 4: Pharmacological cholesterol-lowering treatment in children.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p282 

    The article presents information on the pharmacological cholesterol-lowering treatment in children less than 18 years of age with chronic kidney disease (CKD) and suggests not to initiate the treatment with statins. Topics include trials of dyslipidemias, nutrition and dietary counseling, and...

  • Chapter 1: Assessment of lipid status in adults with CKD.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p268 

    The article presents information on a study related to the assessment of lipid status in adults with chronic kidney disease (CKD) and recommends evaluation with a lipid profile. Topics include determinants of dyslipidemia in CKD including glomerular filtration rate (GFR), diabetes mellitus, and...

  • Pediatric dialysis and renal transplantation in Kuwait over the past 11 years. El-Reshaid, K.; Kapoor, Madan M.; Naryanan Nampoory, M. R.; El-Reshaid, W.; Johny, Kaivilayil V. // Pediatric Nephrology;1999, Vol. 13 Issue 3, p259 

    Data on end-stage renal disease (ESRD) patients and their renal replacement therapy (RRT) were collected retrospectively from the three dialysis centers, the pediatric urology unit, and the organ transplant center of Kuwait. The study period was from 1 January 1986 to 31 December 1996. A total...

  • Strategies for the preservation of residual renal function in pediatric dialysis patients. Cadnapaphornchai, Melissa; Teitelbaum, Isaac // Pediatric Nephrology;May2014, Vol. 29 Issue 5, p825 

    In adults with end-stage renal disease (ESRD), the preservation of residual renal function (RRF) has been shown to be associated with decreased mortality and improved control of complications of chronic kidney disease. However, less is known on the benefits of RRF in the pediatric dialysis...

  • Chapter 2: Pharmacological cholesterol-lowering treatment in adults.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p271 

    The article reflects on the cholesterol-lowering treatment in adults with the help of pharmacological interventions to reduce morbidity and mortality from atherosclerosis. Topics include reduction of risk of adverse cardiovascular events in chronic kidney disease (CKD) populations with the help...

  • Chapter 5: Triglyceride-lowering treatment in adults.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p284 

    The article presents information on a study related to triglyceride-lowering treatment in adults with chronic kidney disease (CKD) and hypertriglyceridemia and recommends therapeutic lifestyle change (TLC). Topics include non-pharmacological treatment such as dietary modification, weight...

  • Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy. Johnson, Rebecca; Warady, Bradley // Pediatric Nephrology;Aug2013, Vol. 28 Issue 8, p1283 

    Background: End-stage renal disease (ESRD) during infancy has been associated with poor short-term neurocognitive outcomes. Limited information exists regarding long-term outcomes. Methods: Neurocognitive outcomes for 12 patients diagnosed with ESRD during the first 16 months of life were...

  • Chapter 2: Pharmacological cholesterol-lowering treatment in adults.  // Kidney International Supplement;Nov2013, Vol. 3 Issue 3, p271 

    The article reflects on the cholesterol-lowering treatment in adults with the help of pharmacological interventions to reduce morbidity and mortality from atherosclerosis. Topics include reduction of risk of adverse cardiovascular events in chronic kidney disease (CKD) populations with the help...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics